• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C100-O20
Device Problems Loss of or Failure to Bond (1068); Leak/Splash (1354); Stretched (1601); Tear, Rip or Hole in Device Packaging (2385)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 10/03/2018
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially treated with an afx system in 2011.During a recent follow-up ct, it appears that the main body and proximal extension separated resulting in endoleak type iiia.In addition, the stent diameter of the proximal extension is measuring at 40mm resulting in an endoleak type iiib.The physician states the patient's aneurysm has been expanding over the last few follow-ups (timeframe and diameter unknown).The patient will be evaluated for possible conversion to open repair and continue to be monitored.As of this report, no additional patient sequelae have been reported.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.A clinical assessment of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Several attempts were made to obtain medical records and images but inadequate records were received.As such, event determination, off label conditions, related patient harms and patient disposition could not be independently assessed.No additional investigation of this reported event is planned.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8037507
MDR Text Key126092812
Report Number2031527-2018-00826
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 10/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2012
Device Model NumberA34-34/C100-O20
Device Lot NumberW11-5048-005
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/03/2018
Initial Date FDA Received11/05/2018
Supplement Dates Manufacturer Received10/03/2018
Supplement Dates FDA Received12/26/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AFX-BIFURCATED-LOT: W11-5403-009; AFX-BIFURCATED-LOT: W11-5403-009
Patient Outcome(s) Other;
Patient Age76 YR
-
-